SCHEMBL4850151

SCHEMBL4850151

CCC(C)(C#N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19033746 1.00
SCHEMBL6859432 0.84
Water SCHEMBL31742532 0.81 ALDH1A1 (0.33)
SCHEMBL1268268 0.81 ALDH1A1 (0.33)
SCHEMBL28593199 0.81 ALDH1A1 (0.33)
SCHEMBL7808507 0.80
SCHEMBL16083906 0.80
SCHEMBL14440873 0.79 CTSS (0.33)
SCHEMBL9755816 0.78 TSHR (0.33)
SCHEMBL31346428 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228506-A1 RIPK1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2024-07-11 US disclosed
EP-4329766-A1 RIPK1 INHIBITORS AND METHODS OF USE Merck Sharp & Dohme LLC (US) 2024-03-06 EP disclosed
CN-114044743-B Preparation method of ethyl 2-cyanopropionate 西安凯立新材料股份有限公司 2023-10-17 CN disclosed
WO-2022231928-A1 RIPK1 INHIBITORS AND METHODS OF USE MERCK SHARP & DOHME LLC (US) 2022-11-03 WO disclosed
EP-3079701-B1 SOLUBLE GUANYLATE CYCLASE ACTIVATORS MERCK SHARP & DOHME (US) 2021-08-11 EP disclosed
US-10889589-B2 Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain ARRAY BIOPHARMA INC. (US) 2021-01-12 US disclosed
CN-107602584-B Compound for organic electric element, organic electric element using same, and electronic device using same 德山新勒克斯有限公司 2020-11-03 CN disclosed
US-20190270749-A1 BICYCLIC UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF PAIN ARRAY BIOPHARMA INC. (US) 2019-09-05 US disclosed
US-10351575-B2 Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain ARRAY BIOPHARMA INC. (US) 2019-07-16 US disclosed
US-10323022-B2 Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors ARRAY BIOPHARMA INC. (US) 2019-06-18 US disclosed
EP-0741127-B1 Synthesis of cyanoacrylate esters by oxidation of aromatic selenyl cyanopropionates LOCTITE CORP (US) 1999-04-07 EP disclosed
CN-1212722-A Cold accumulation material for ultra-low temp., refrigerating machine using the material and heat shield material TOSHIBA KK (JP) 1999-03-31 CN disclosed
WO-1998059108-A2 OXIDATION AND BLEACHING SYSTEM WITH ENZYMATICALLY PRODUCED OXIDIZING AGENTS BLUME, HILDEGARD (DE) 1998-12-30 WO disclosed
WO-1998016826-A1 IMMUNOASSAY FOR THE DETECTION AND MEASUREMENT OF 2,2-DIBROMO-3-NITRILOPROPIONAMIDE THE DOW CHEMICAL COMPANY (US) 1998-04-23 WO disclosed
EP-0741127-A1 Synthesis of cyanoacrylate esters by oxidation of aromatic selenyl cyanopropionates LOCTITE CORPORATION (US) 1996-11-06 EP disclosed
US-5504252-A Synthesis of cyanoacrylate esters by oxidation of aromatic selenyl cyanopropionates LOCTITE CORPORATION (US) 1996-04-02 US disclosed
EP-0290570-B1 CHIRAL OR ACHIRAL CYCLIC COMPOUNDS MERCK PATENT GmbH (DE) 1992-09-23 EP disclosed
EP-0290570-A1 CHIRAL OR ACHIRAL CYCLIC COMPOUNDS. MERCK PATENT GMBH (DE) 1988-11-17 EP disclosed
WO-1988003530-A1 CHIRAL OR ACHIRAL CYCLIC COMPOUNDS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1988-05-19 WO disclosed
US-4299979-A CORROSION RESISTANT COATING DESOTO, INC. (US) 1981-11-10 US disclosed